Case of de novo psoriasis possibly triggered by nivolumab

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of dermatology 2017-01, Vol.44 (1), p.99-100
Hauptverfasser:	Murata, Susumu, Kaneko, Sakae, Harada, Yuji, Aoi, Noriaki, Morita, Eishin
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Cutaneous Aged, 80 and over Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Betamethasone - administration & dosage Betamethasone - analogs & derivatives Betamethasone - therapeutic use Calcitriol - administration & dosage Calcitriol - analogs & derivatives Calcitriol - therapeutic use Drug Combinations Humans Male Melanoma - drug therapy Melanoma - pathology Neoplasm Recurrence, Local - drug therapy Neoplasm Staging Programmed Cell Death 1 Receptor - antagonists & inhibitors Programmed Cell Death 1 Receptor - metabolism Psoriasis - chemically induced Psoriasis - diagnosis Psoriasis - immunology Psoriasis - pathology Signal Transduction - immunology Th1 Cells - immunology Th17 Cells - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!